BullishMEDIUM severityHealthcare & Pharma93d ago

Schrödinger outlines 10%-15% 2026 ACV growth as Bristol Myers Squibb deploys Bunsen

Schrödinger outlines 10%-15% 2026 ACV growth as Bristol Myers Squibb deploys Bunsen — $BMY one-month chart
$BMY daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about BMY. Get explanations, comparisons and calculations with the source lookups shown.

Wook analysis

What it means

Key points
  • What to watch: There is a hard number in this story (10%) — the interesting part is how it compares with the last few like it.
  • How the stock is trading: $BMY -1.57% in the latest session.
  • Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Change10%
Change-15%

Where the stock stands

$BMY last traded at $62.14, -1.57% on the session. That puts it 9.5% shy of its 52-week high of $68.64 and 37% clear of its low of $45.27 — in the upper part of the range. Over the year it has ranged 52% from low to high: a wide band — moves of several percent in a week come with the territory. These are latest-session quotes, not live prices — the live tape is on the $BMY page.

How much coverage it is getting

In the last 30 days Wook has filed 2 stories about $BMY — 2 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 0 read bullish, 2 neutral and 0 bearish — mostly headline writers keeping a straight face. This one reads bullish, so it sits in a small minority of the run. 12 related stories from the same name or desk are listed beside this one.

The bigger picture

Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.

What to watch next

For the receipts, the $BMY page has the full chart, the filings and the valuation model these figures come from. Comparing how two or three outlets frame the same story is the fastest way to separate the facts from the angle. And Wook AI, up top, will happily do the math — how far $BMY sits from its high, or how this week's coverage stacks up.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on August 6, 2026. $BMY has moved -3.13% ($64.15 to $62.14). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what this browser shares. Essential sign-in and security cookies stay on.

Read the privacy policy